Drugs / alpha B-crystallin
alpha B-crystallin
also known as
recombinant human alpha B-crystallin
Protein / enzyme biologic targets TLR2 via activation
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02442570 Comparator | Sep 2012 → Jun 2014 | multiple sclerosis | Delta Crystallon BV | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | alpha B-crystallin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02442570 ↗ |
| Known as | recombinant human alpha B-crystallin | “a solution of recombinant human alpha B-crystallin” NCT02442570 ↗ |
| Action | Activate | “activator of Toll-like receptor 2-mediated protective responses” PMID 26599332 ↗ Nov 2015 |
| Modality | Protein / enzyme biologic | “the small heat shock protein alpha B-crystallin (HspB5)” PMID 26599332 ↗ Nov 2015 |
| Target | TLR2 | “activator of Toll-like receptor 2-mediated protective responses” PMID 26599332 ↗ Nov 2015 |